Brief IA
›

Sam Altman: Curing Cancer Isn't Enough to Convince on AI

Models & LLM·Tom Levy·

Sam Altman: Curing Cancer Isn't Enough to Convince on AI

Sam Altman: Curing Cancer Isn't Enough to Convince on AI
Key Takeaways
1Sam Altman believes that AI must aim beyond curing cancer to regain public trust
2Dario Amodei initially championed this promise before labeling it a misleading cliché
340% of Americans anticipate a negative impact from AI, compared to 16% who expect a positive one, according to Pew Research Center
Why it matters : The debate over AI promises and public distrust influences how industry leaders communicate and set their goals.

The head of OpenAI believes that the horizon of "curing cancer" is too narrow to win over skeptics. Dario Amodei at Anthropic defended this idea before himself labeling it a misleading cliché. Both advocate for an open debate, as hostility towards AI deployment grows and public opinion remains divided.

Public Dialogue Advocated, but Worrying Remarks

Sam Altman and Dario Amodei argue that it is essential to maintain a dialogue about AI, even when discussions are challenging. Sam Altman asserts that it is necessary to publicly reflect on negative scenarios and what might happen, without spreading despair or concentrating power, and he claims that solutions come through open debate. However, he acknowledges that this intention sometimes frightens the public. Dario Amodei writes that the most accurate criticism directed at AI companies, including Anthropic, is that they have not yet fulfilled their grand promises of benefit to the world.

American Opinion: 40% Anticipate a Negative Impact from AI

According to the Pew Research Center, about 40% of Americans predict a negative impact of AI on society, while only 16% foresee it as positive. Meanwhile, trust in AI has declined, with protests against data centers and bans on the technology in certain schools. The rejection of some projects is becoming a political issue, and workers express concerns about potential disruptions in the job market.

Le brief IA que lisent les pros

Le brief IA que les pros lisent chaque soir

Les 7 actus IA du jour, décryptées en 5 min. Gratuit.

Inclus dès l'inscription : notre sélection des meilleurs guides & comparatifs IA.

Choisissez votre rythme

Gratuit · Pas de spam · Désabonnement en 1 clic

For Sam Altman, Aiming Beyond Curing Cancer

Sam Altman argues that AI must go beyond the prospect of curing cancer to gain the trust of skeptics. He believes that the tech industry has done a "terrible job" of highlighting the positive aspects of AI while trust deteriorates. He contends that curing cancer would not be enough, even though it would be a valuable advancement, and calls for aiming higher. According to him, AI should also foster a surge in creativity and entrepreneurship, a message he feels is lost in the public debate. He emphasizes the need for technology to provide more autonomy and power to individuals, noting that fears are understandable if the public perceives the opposite. He finally reminds that some leaders advocate for a vision of abundance associated with AI, including remedies for diseases like cancer.

Anthropic's Position: From the "Cure" Bet to the Recognition of a Cliché

Dario Amodei initially argued that "truly curing" cancer through AI would be a way to fulfill the promises of technology and win over the public. He reaffirmed last month that winning public opinion would hinge on such a tangible success. However, he also writes that promising that AI will cure cancer has become a cliché that seems misleading to many, marking a shift in his own framing of the objective.

Brief IA — L'actualité IA en français

L'essentiel de l'actualité de l'intelligence artificielle, décrypté et expliqué chaque jour.